Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.

Autor: Jaiyesimi IA; Corewell Health William Beaumont University Hospital, Royal Oak and Oakland University William Beaumont School of Medicine, Rochester, MI., Leighl NB; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Ismaila N; American Society of Clinical Oncology (ASCO), Alexandria, VA., Alluri K; St Luke's Mountain States Tumor Institute, Boise, ID., Florez N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Gadgeel S; Henry Ford Cancer Institute/Henry Ford Health System, Detroit, MI., Masters G; Helen F. Graham Cancer Center and Research Institute, Newark, DE., Schenk EL; University of Colorado Anschutz Medical Center, Aurora, CO., Schneider BJ; University of Michigan Health System, Ann Arbor, MI., Sequist L; Massachusetts General Hospital, Boston, MA., Singh N; Postgraduate Institute of Medical Education and Research, Chandigarh, India., Bazhenova L; University of California San Diego Moores Cancer Center, San Diego, CA., Blanchard E; Southcoast Centers for Cancer Care, New Bedford, MA., Freeman-Daily J; The ROS1ders, Seattle, WA., Furuya N; St Marianna University School of Medicine, Kawasaki, Japan., Halmos B; Montefiore Einstein Center for Cancer Care, Bronx, NY., Azar IH; IHA Hematology Oncology Consultants, Ypsilanti, MI., Kuruvilla S; London Health Sciences Centre, London, ON, Canada., Mullane M; Aurora Cancer Care, Mount Pleasant, WI., Naidoo J; Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD., Reuss JE; Georgetown University, Washington, DC., Spigel DR; Sarah Cannon Research Institute, Nashville, TN., Owen DH; Ohio State University, Columbus, OH., Patel JD; Northwestern University, Chicago, IL.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Apr 10; Vol. 42 (11), pp. e1-e22. Date of Electronic Publication: 2024 Feb 28.